Can AI unravel the mysteries of human biology? Could it help design specialty treatments and cures for disease? Geoffrey von Maltzahn and his team at Generate:Biomedicines are bullish on both counts. AI has greatly accelerated progress in genome engineering, bioengineering and nanotechnology and they are getting closer to developing tailored therapeutics. “Six years ago, this was a crazy idea,” he says. “We’re now convinced that 100 percent of protein therapeutics are going to get created this way.” In this special episode of Solve for X, host Manula Selvarajah sits down with von Maltzahn to talk about where the science is now and where it is headed.